Ameriprise’s Principal Exchange-Traded Funds Principal Healthcare Innovators ETF BTEC Stock Holding History
Bought
Maintained
Sold
Other funds holding BTEC
FFG
VNA
RJFSA
ECA
FTUS
Ameriprise's BTEC Position: Q1 2022 in Review
Ameriprise sold out of Principal Exchange-Traded Funds Principal Healthcare Innovators ETF (BTEC) in Q1 2022, closing a stake of 5,653 shares — an estimated $267K sold.
Ameriprise first reported a position in BTEC in Q4 2020 and held it in 4 quarters. The position peaked at $1.43M in Q4 2020. 31 funds tracked by Wall St. Rank hold BTEC as of Q1 2022.
- Ameriprise reported no remaining Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position as of Q1 2022 after selling out during the quarter.
- Ameriprise sold 5,653 Principal Exchange-Traded Funds Principal Healthcare Innovators ETF shares in Q1 2022, an estimated $267K.
- Ameriprise first reported a position in Principal Exchange-Traded Funds Principal Healthcare Innovators ETF in Q4 2020 and held it in 4 quarters.
- Ameriprise's Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position peaked at $1.43M in Q4 2020.
- 31 funds tracked by Wall St. Rank held Principal Exchange-Traded Funds Principal Healthcare Innovators ETF as of Q1 2022.
Based on Ameriprise's 13F filing for Q1 2022, filed 16 May 2022.